Dopamine D2 receptors — Drug Target

All drugs that target Dopamine D2 receptors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Antipsychotic

Marketed (1)

• Flupentixole · Technical University of Munich · Antipsychotic · Neuroscience
  Flupentixole is a dopamine D2 receptor antagonist that reduces psychotic symptoms by blocking dopamine receptors in the brain.